BioAlliance Pharma
14Patents
7Active
14Granted
40Portfolio score
Filing activity: Aug 25, 2000 → Jul 16, 2013 · 5 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6881421B1 | Nanoparticles comprising at least one polymer and at least one compound able to complex one or more active ingredients | Performing Operations; Transporting | 47 | Expired |
| US6916485B2 | Prolonged release bioadhesive therapeutic systems | Human Necessities | 44 | Expired |
| US7651698B2 | Prolonged release bioadhesive therapeutic systems | Human Necessities | 14 | Active |
| US7022832B2 | Oligonucleotides containing an antisense sequence stabilized by a secondary structure, pharmaceutical compositions containing them and method of blocking gene expression using them | Chemistry; Metallurgy | 4 | Expired |
| US8211466B2 | Mucosal bioadhesive slow release carrier for delivering active principles | Human Necessities | 4 | Active |
| US7064133B2 | Quinoline derivatives process of synthesis and medicaments containing these derivatives | Human Necessities | 1 | Expired |
| US7479497B2 | Use of quinoline derivatives with anti-integrase effect and applications thereof | Human Necessities | 1 | Expired |
| US8062669B2 | Vectorization system comprising nanoparticles of homogenous size of at least one polymer and at least one positively charged polysaccharide and method for the preparation thereof | Emerging Cross-Sectional Technologies | 0 | Expired |
| US8791127B2 | Mucosal bioadhesive slow release carrier for delivering active principles | Human Necessities | 0 | Active |
| US8227435B2 | Electrotransfer of nucleic acid into tissue cells | Human Necessities | 0 | Active |
| US8518442B2 | Prolonged release bioadhesive therapeutic systems | Human Necessities | 0 | Active |
| US7491505B2 | Method for analyzing tumor aggressivity comprising measurement of polymerized actin | Physics | 0 | Expired |
| US8747896B2 | Mucosal bioadhesive slow release carrier for delivering active principles | Human Necessities | 0 | Active |
| US8592434B2 | Mucoadhesive buccal tablets for the treatment of orofacial herpes | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.